Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00101478 · ClinicalTrials.gov registry record
Improving Cardiovascular Treatment Approaches Among Minorities
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 823
- Enrollment target
NCT00101478: Completed study, sponsored by University of Maryland, Baltimore.
NCT00101478 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 823 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00101478 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 823 participants
- Enrollment target
Study Summary
The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities. Specifically, the study will aim to improve provider and patient approaches to treatment of hypertension and diabetes, respectively.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 823 participants |
| Start Date | 2004-09 |
| Est. Completion | 2011-01 |
What the finished NCT00101478 record still lists
NCT00101478 is an observational study that tracks outcomes without assigning an intervention. The registered 823 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00101478 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00101478 about?
NCT00101478 is a clinical study titled "Improving Cardiovascular Treatment Approaches Among Minorities". The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities. Specifically, the study will aim to improve provider and patient approaches to treatment of hypertension and diabetes, respectively.
What is the current status of trial NCT00101478?
This trial is currently completed. The enrollment target is 823 participants. The study started on 2004-09. Estimated completion is 2011-01.
Who is sponsoring clinical trial NCT00101478?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06944509 · 824 participants · NA
RADIQAL Study (Radiation Dose and Image Quality Trial)
- NCT05679349 · 822 participants · NA
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
- NCT06091254 · 822 participants · Phase 3
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- NCT07357389 · 822 participants · NA
Virtual Reality for ICU Delirium Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia